Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners.
about
Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletesCell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsThe Exercise Rehabilitation Paradox: Less May Be More?Utility of magnetic resonance imaging in the evaluation of left ventricular thickening.Phidippides cardiomyopathy: a review and case illustration.Potential adverse cardiovascular effects from excessive endurance exercise.Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy.Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations.Pre-participation and follow-up screening of athletes for endurance sport.Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship.The impact of repeated marathon running on cardiovascular function in the aging populationWhole-body MRI and MRA for evaluation of the prevalence of atherosclerosis in a cohort of subjectively healthy individualsT1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise?Endurance Sport Activity and Risk of Atrial Fibrillation - Epidemiology, Proposed Mechanisms and Management.Nonischemic Left Ventricular Scar as a Substrate of Life-Threatening Ventricular Arrhythmias and Sudden Cardiac Death in Competitive AthletesThe incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation .Physiologic and pathophysiologic changes in the right heart in highly trained athletes.Exercise and the heart: the good, the bad, and the ugly.Cardiac imaging to detect coronary artery disease in athletes aged 35 years and older. A scoping review.Medico-legal perspectives on sudden cardiac death in young athletes.Is marathon running toxic? An observational study of cardiovascular disease prevalence and longevity in 54 male marathon runners.Diagnosis, pathophysiology, and management of exercise-induced arrhythmias.Coronary atherosclerosis burden, but not transient troponin elevation, predicts long-term outcome in recreational marathon runners.Running multiple marathons is not a risk factor for premature subclinical vascular impairment.Excessive Exercise Habits in Marathoners as Novel Indicators of Masked Hypertension.Delayed enhancement of the intraventricular septum following an extraordinary endurance exercise.Lifelong Physical Activity Regardless of Dose Is Not Associated With Myocardial Fibrosis.Do marathon runners face an "ominous" risk of myocardial fibrosis?Mortality of French participants in the Tour de France (1947-2012).Correlation between ECG abnormalities and cardiac parameters in highly trained asymptomatic male endurance athletes: evaluation using cardiac magnetic resonance imaging.Global and regional cardiac function in lifelong endurance athletes with and without myocardial fibrosis.The Right Heart: Acute and Chronic Issues.The impact of remote ischemic preconditioning on cardiac biomarker and functional response to endurance exercise.Acute cardiac effects of marathon running.Exercise and sports in cardiac patients and athletes at risk: Balance between benefit and harm.Acute and Chronic Response to Exercise in Athletes: The "Supernormal Heart".Application of single shot free-breathing fast imaging employing steady state sequence in cardiac magnetic resonance imaging.Subepicardial delayed gadolinium enhancement in asymptomatic athletes: let sleeping dogs lie?Rebuttal from Eduard Guasch and Stanley Nattel.
P2860
Q24609702-3590A1B9-B9DC-40E7-92D7-AB01E458C09BQ27001159-E1C6A7D7-9401-4199-8FF7-AC69FDDE29DAQ28079073-BED77242-AE3D-44C8-BE8A-B55F084CACF0Q30359543-F3022492-6ADB-48D8-A5DF-5E290F9E6CE1Q34245017-7C4D28F8-966F-4A8F-9FB0-DECD2E74199CQ34279670-BEC54440-FB3E-46E3-B842-E7734F506271Q35102865-F417AFAF-F2D7-483B-B7AC-BDA2DAA79C15Q35115127-D48ECF02-AB61-47CC-B1C5-3A676BAC9B72Q35387152-644429B9-B36C-4CE0-8E7A-46C9DC60D4F4Q35672150-60EB025E-8887-4A25-94B3-B65A018D193FQ36222553-1AF1E62F-379F-49F5-BB8B-C84AC24B47C3Q36236566-9D3C366C-9872-41E0-8389-E3D426B603E1Q36417705-F3DD80FD-4589-4F6D-A53D-3157540CF4C9Q36422461-0114428D-B1D0-4E1A-9645-1920DFC48D1DQ36458821-BC67E282-D470-4031-A131-2DBB6E83FF3FQ37116397-CBABF9B6-1982-49A7-8C65-4E49779EFF5CQ37537964-604BDC8C-D89E-4546-8C1A-2CAD7C4CD6B3Q38395750-3AE6E339-040F-4E2C-89DD-5104D1F8F5B1Q38403824-5CA16EDC-C7FE-4F35-B026-EBDA7630CE7CQ38612036-2F0C427A-9A49-41DA-95C4-43226408A836Q38961073-585AD90B-8EE2-4A8C-BFAE-894A540A1F03Q38991659-E1E34447-F012-40E5-8E05-D5E8085DDA1CQ39004326-C0FFD13A-059D-4930-B2CF-02A54B9EE93DQ39311794-A455BBBE-B453-45FA-8C77-2080CB856043Q40170595-87A03756-3BE9-4C9F-A180-7C2D40C29032Q42319159-AB453B63-9EA1-4DD6-9A78-3AC3E993DD75Q42581746-3C8A044C-7DDA-47DF-8F0B-55CE7312F43DQ42803984-52F10B19-AA44-4FAD-8507-543B45E8B634Q44256431-439FDD33-4C8B-4611-A1C6-F23829BA6FB8Q45081591-21017226-C723-4A88-9B80-47DFE86AF5ECQ47590128-1781AC11-46EE-47F5-9EDC-C12091EDF3B1Q47769233-E7ED214D-D487-4D83-A4AA-250A99674643Q47921631-90D47529-F0E0-4FDB-8BC7-5FABB79B24DDQ48154940-86FD2EB9-0A87-4399-AAC9-C2DB27682334Q48310607-EFD56525-C4FA-4E68-B4FF-674854E9913BQ49126226-F13FD087-109D-48CA-86F1-53E5C151C121Q50096376-FE36BC77-2379-49D3-A440-93FF0CE08115Q51105617-5F92623E-8CFF-4E10-9477-917ABEA22D08Q53401947-FB228060-440E-4A81-8F06-4EC2D5A3DE9BQ54751001-97A0AACD-27AD-46F5-B304-5D5B0569D5AF
P2860
Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Myocardial late gadolinium enh ...... relevance in marathon runners.
@en
Myocardial late gadolinium enh ...... relevance in marathon runners.
@nl
type
label
Myocardial late gadolinium enh ...... relevance in marathon runners.
@en
Myocardial late gadolinium enh ...... relevance in marathon runners.
@nl
prefLabel
Myocardial late gadolinium enh ...... relevance in marathon runners.
@en
Myocardial late gadolinium enh ...... relevance in marathon runners.
@nl
P2093
P1433
P1476
Myocardial late gadolinium enh ...... relevance in marathon runners
@en
P2093
Axel Schmermund
Burkhard Sievers
Gerd Heusch
Jörg Barkhausen
Kai Nassenstein
Karl-Heinz Jöckel
Nils Lehmann
Stefan Möhlenkamp
Susanne Ladd
Thomas Schlosser
P356
10.1148/RADIOL.2511081118
P407
P577
2009-04-01T00:00:00Z